Cystic echinococcosis (CE) is a high prevalence zoonosis among the rural population of Tacuarembó (Uruguay). The correlation between serological data and the incidence of risk factors was studied in a survey carried out in 1998 among rural communities where 480 individuals were examined by means of abdominal sonography (local prevalence = 0.8%). Serum samples (305) were analysed by ELISA to determine specific IgG against crude antigens from Echinococcus granulosus. A total of 27 individuals exhibiting no detectable changes in abdominal sonographic examination were found to be seropositive ('ultrasound normal group'). Of these individuals 9 were seroreactive against purified antigen B. A significant degree of correlation was found between seroreactivity and the incidence of some risk factors (CE antecedent in the family, P < 0.005 and use of rural water, P < 0.0001) among this group. Follow-up of individuals of the 'ultrasound normal group' was carried out after 2 years to evaluate the implications of this serological reactivity. No predictive value for cyst development was assessed with complementary image study; in contrast transient antibodies were observed with both crude and purified antigen as approximately 60% of individuals became negative when re-sampled.
Cystic echinococcosis is a highly endemic parasitic zoonosis that is present in the
Southern Cone countries of America. For several decades, various prevention and
control programmes have been implemented in different countries and regions, with
varying results. In Uruguay, a new control programme was implemented in 2006 that
employed new strategies for canine diagnosis and treatment, dog population control,
diagnosis in humans, epidemiological surveillance, and health education, including
community participation. The control programme in Uruguay addresses the control and
surveillance of the disease from a holistic perspective based on Primary Health Care,
which has strengthened the community’s participation in developing and coordinating
activities in an interdisciplinary manner. Similarly, the control programme that is
currently implemented is based on a risk-focused approach. The surveillance and
control measures were focused on small villages and extremely poor urban areas. In
this study, the strategies used and the results obtained from 2008-2013 are analysed
and discussed.
Cystic echinococcosis (CE) or hydatidosis, a parasitic zoonosis caused by a cestode of the family Taeniidae, species Echinococcus granulosus, is endemic in Argentina, Chile, Peru, Uruguay, and southern Brazil. This report presents CE figures for these five countries in 2009 – 2014 and proposes indicators to measure national control programs.
Nearly 5 000 new CE cases were diagnosed annually in the five countries during the study period. The average case fatality rate was 2.9%, which suggests that CE led to approximately 880 deaths in these countries during the 6-year period. CE cases that required secondary or tertiary health care had average hospital stays of 10.6 days, causing a significant burden to health systems. The proportion of new cases (15%) in children less than 15 years of age suggests ongoing transmission.
Despite figures showing that CE is not under control in South America, the long-standing implementation of national and local control programs in three of the five countries has achieved reductions in some of the indicators. The Regional Initiative for the Control of CE, which includes the five countries and provides a framework for networking and collaboration, must intensify its efforts.
Cystic echinococcosis is a zoonosis caused by a cestode, Echinococcus granulosus, of the Taeniidae family. The adult form of the tapeworm affects canids, particularly dogs and foxes, while the larva is harbored by sheep, cattle, goats and other mammals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.